share_log

Mangoceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jacob D. Cohen(34.2%),The Tiger Cub Trust(30.3%)

SEC ·  Aug 28 07:50
Summary by Futu AI
On August 27, 2024, Mangoceuticals, Inc. experienced a significant change in its shareholder structure, as detailed in the latest Schedule 13D/A filing with the United States Securities and Exchange Commission. Jacob D. Cohen, a major shareholder, reported a transfer of 800,000 shares of common stock to The Tiger Cub Trust, an entity he controls, without any consideration. This amendment, identified as Amendment No. 3, supplements previous filings made on May 3, 2023, January 2, 2024, and June 5, 2024. Following this gifting of shares, Jacob D. Cohen and The Tiger Cub Trust collectively hold an aggregate of 10,825,000 shares, representing 34.2% of the company's issued common stock. The Tiger Cub Trust alone holds 9,075,000 shares, accounting for 30.3% of the common stock. The filing also notes that Cohen has sole voting and dispositive power over 1,750,000 shares, which includes shares issuable upon the exercise of vested options. The total number of common shares outstanding as confirmed by Mangoceuticals' transfer agent is 29,905,803.
On August 27, 2024, Mangoceuticals, Inc. experienced a significant change in its shareholder structure, as detailed in the latest Schedule 13D/A filing with the United States Securities and Exchange Commission. Jacob D. Cohen, a major shareholder, reported a transfer of 800,000 shares of common stock to The Tiger Cub Trust, an entity he controls, without any consideration. This amendment, identified as Amendment No. 3, supplements previous filings made on May 3, 2023, January 2, 2024, and June 5, 2024. Following this gifting of shares, Jacob D. Cohen and The Tiger Cub Trust collectively hold an aggregate of 10,825,000 shares, representing 34.2% of the company's issued common stock. The Tiger Cub Trust alone holds 9,075,000 shares, accounting for 30.3% of the common stock. The filing also notes that Cohen has sole voting and dispositive power over 1,750,000 shares, which includes shares issuable upon the exercise of vested options. The total number of common shares outstanding as confirmed by Mangoceuticals' transfer agent is 29,905,803.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.